Amplia Therapeutics Ltd.ASX: ATX

Amplia Initiates Multiple Dose Study of AMP945

Feb 17, 2021 at 2:27 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment